Prognostic and predictive value of p53 and p21 in breast cancer.
about
The pathology of familial breast cancer: Immunohistochemistry and molecular analysisp21(waf) correlates with DNA replication but not with prognosis in invasive breast cancerGenome changes and gene expression in human solid tumors.COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situModeling cancer progression via pathway dependenciesComparative study of gene set enrichment methods.Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neckMutations in p53, p53 protein overexpression and breast cancer survivalRB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patientsThe p53 tumor suppressor gene in ductal carcinoma in situ of the breast.Clinical uses of tumor markers: a critical review.Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoringLiposomal nanomedicine for breast cancer therapy.Clinical utility of reverse phase protein array for molecular classification of breast cancer.Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors.Impact of differential cyclin D1 expression and localisation in prostate cancer.Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.p53 protein accumulation and presence of visceral metastasis are independent prognostic factors for survival in patients with metastatic inflammatory breast carcinoma.Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.Proliferation rate, hormone receptor status and p53 expression in skeletal metastasis of breast carcinoma.Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assayCorrelation of p53 Mutations in ThinPrep-Processed Fine Needle Breast Aspirates with Surgically Resected Breast CancersVascular Endothelial Growth Factor Expression Correlates with p53 Mutation and Angiogenesis in Squamous Cell Carcinoma of the Head and Neck
P2860
Q24800411-719A4416-60F8-4829-9800-6B1DF1EE5A81Q28362835-3805C355-67FE-4E14-837B-14496CA0EBCDQ30841588-46E9EC4B-D563-4D10-8821-45B0C8F4AB53Q33317621-8CB738D5-FB15-441D-8CD0-0FB028E006A7Q33320177-00DDA16C-B178-47FD-8929-BDE20AD85747Q33499521-440565DB-80B2-495E-98EB-18760C8F1B10Q33615319-C54AF98F-44CC-4FB2-A0AF-B81BF9DADF2BQ33703486-E4A0B28F-BD0D-4047-80C7-3F51964B077AQ33784718-761617C1-19B5-4CB0-8545-CF4402E860A2Q33810039-2D392A9D-35B4-4A79-9B57-794FE6CB0D94Q34307441-7BB10A7E-0903-4B33-ACE8-005CB501DDB7Q35157568-1CD7B0FB-BF8E-4C88-9E91-5239CCAFCE09Q36643624-E99A3DC5-1E7A-419F-9833-5EAED831B655Q37939968-7A32C792-FCB7-43C9-9888-DE738BBEC836Q38383140-75B95803-D078-48AC-8CD4-E4B5CBF792D5Q40337704-4025F8CD-C3FB-42FA-B515-7D6E059E0257Q40771337-CDA5C162-92AD-479A-997A-400534E3ED84Q42132289-AF18E2F7-F973-4FC9-AB7A-EBCFFB033764Q43153660-DE3821B8-FA61-41D7-ABF6-0508A42E9F3DQ43818075-F318AD69-44AC-4566-9654-40FC37558A32Q44674958-7278DB82-0FE4-4C30-BA54-9D17AEAC59A8Q44971108-21BD35AB-D214-4F61-B030-0F7D0251B33FQ45053697-2D9A3DC8-DB45-40E6-A750-D72E80BBF6E9Q55219319-95D793E3-DDAD-4C28-8A5A-03890DD8024CQ57580915-4D6DD9CB-8C75-4A90-81E7-A1D10234B6B1Q57735569-98D9E92C-D751-4906-ACB0-62660E95785CQ58284543-B40F23AC-F31D-4C65-B953-8289C678B8D4
P2860
Prognostic and predictive value of p53 and p21 in breast cancer.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Prognostic and predictive value of p53 and p21 in breast cancer.
@ast
Prognostic and predictive value of p53 and p21 in breast cancer.
@en
Prognostic and predictive value of p53 and p21 in breast cancer.
@nl
type
label
Prognostic and predictive value of p53 and p21 in breast cancer.
@ast
Prognostic and predictive value of p53 and p21 in breast cancer.
@en
Prognostic and predictive value of p53 and p21 in breast cancer.
@nl
prefLabel
Prognostic and predictive value of p53 and p21 in breast cancer.
@ast
Prognostic and predictive value of p53 and p21 in breast cancer.
@en
Prognostic and predictive value of p53 and p21 in breast cancer.
@nl
P2860
P356
P1476
Prognostic and predictive value of p53 and p21 in breast cancer.
@en
P2093
P2860
P2888
P356
10.1023/A:1006163101948
P407
P577
1998-01-01T00:00:00Z
P6179
1050968526